Details for 2022156122

Up to date per 28.05.2026

Actions

Title / Product Name

GLP-1-REZEPTORANTAGONIST ZUR BEHANDLUNG VON POSTPRANDIALER HYPOGLYKÄMIE ODER ANGEBORENEM HYPERINSULINISMUS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2022156122

EP Publication Number

4049673

E-Number

1880315

Language

PCT Number

Publication Date

31.08.2022 A

28.01.2026 B1

Registration Date

28.01.2026

AT Publication Date

15.02.2026

Application Date

08.01.2008

Registration Number

Priorities

08.01.2007

87903307 P

IPC

A61K 38/26 20060101AFI20220627BHEP

Maximum Duration of Protection

08.01.2028

Owner

The Trustees of the University of Pennsylvania3160 Chestnut Street, Suite 200 Philadelphia, PA 19104-6283US

Children's Hospital of Philadelphia3401 Civic Center Boulevard Philadelphia, PA 19104US

Representative

No representatives present

Inventor

STOFFERS, Doris Moorestown 08057US

DE LEON, Diva D Penn Valley 19072US

STANLEY, Charles Drexel Hill 19026US